Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00296686 · ClinicalTrials.gov registry record · Phase 4
Sequential Tranylcypromine (TC), TC + Dextroamphetamine and TC + Triiodothyronine for Refractory Depression
A Phase 4 study, sponsored by New York State Psychiatric Institute.
- Terminated
- Registry status
- Phase 4
- Development phase
- 31
- Enrollment target
NCT00296686 is a Phase 4 study that was terminated before completion, run by New York State Psychiatric Institute. The registered enrollment target is 31 participants.
The verdict
NCT00296686, a Phase 4 study, was terminated before completion, sponsored by New York State Psychiatric Institute.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 31 participants
- Enrollment target
Study Summary
This pilot study will assess the efficacy of several sequential pharmacological treatments for patients with Refractory Depression.
Interventions
- DRUG Dextroamphetamine
- DRUG Triiodothyronine
- DRUG Tranylcypromine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 31 participants |
| Start Date | 2001-09 |
| Est. Completion | 2006-08 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00296686
The ClinicalTrials.gov registry entry for NCT00296686 describes a study currently listed as terminated, categorized as Phase 4. The registered enrollment target is 31 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is New York State Psychiatric Institute, which has 364 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Dextroamphetamine is the first listed.
NCT00296686 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00296686 about?
NCT00296686 is a clinical study titled "Sequential Tranylcypromine (TC), TC + Dextroamphetamine and TC + Triiodothyronine for Refractory Depression". This pilot study will assess the efficacy of several sequential pharmacological treatments for patients with Refractory Depression.
What is the current status of trial NCT00296686?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 31 participants. The study started on 2001-09. Estimated completion is 2006-08.
What interventions are being tested in trial NCT00296686?
The interventions under investigation include: Dextroamphetamine (DRUG), Triiodothyronine (DRUG), Tranylcypromine (DRUG).
Who is sponsoring clinical trial NCT00296686?
This trial is sponsored by New York State Psychiatric Institute, which has 364 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.